These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33063403)

  • 1. miR-301b and NR3C2 co-regulate cells malignant properties and have the potential to be independent prognostic factors in breast cancer.
    Peng Y; Xi X; Li J; Ni J; Yang H; Wen C; Wen M
    J Biochem Mol Toxicol; 2021 Feb; 35(2):e22650. PubMed ID: 33063403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-301b-3p Regulates Breast Cancer Cell Proliferation, Migration, and Invasion by Targeting NR3C2.
    Fan Y; Li Y; Zhu Y; Dai G; Wu D; Gao Z; Zhang L; Xu D
    J Oncol; 2021; 2021():8810517. PubMed ID: 33542733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-301b-3p Promotes the Occurrence and Development of Breast Cancer Cells via Targeting HOXA5.
    Lu X; Duan J; Zhou R; Xu Y
    Crit Rev Eukaryot Gene Expr; 2021; 31(3):35-44. PubMed ID: 34369713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2.
    Yang S; He P; Wang J; Schetter A; Tang W; Funamizu N; Yanaga K; Uwagawa T; Satoskar AR; Gaedcke J; Bernhardt M; Ghadimi BM; Gaida MM; Bergmann F; Werner J; Ried T; Hanna N; Alexander HR; Hussain SP
    Cancer Res; 2016 Jul; 76(13):3838-50. PubMed ID: 27197190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-4709 overexpression facilitates cancer proliferation and invasion via downregulating NR3C2 and is an unfavorable prognosis factor in colon adenocarcinoma.
    Yu M; Yu HL; Li QH; Zhang L; Chen YX
    J Biochem Mol Toxicol; 2019 Dec; 33(12):e22411. PubMed ID: 31621980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-454 performs tumor-promoting effects in oral squamous cell carcinoma via reducing NR3C2.
    Guo JY; Wang YK; Lv B; Jin H
    J Oral Pathol Med; 2020 Apr; 49(4):286-293. PubMed ID: 32170966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NR3C2-Related Transcriptome Profile and Clinical Outcome in Invasive Breast Carcinoma.
    Lu J; Hu F; Zhou Y
    Biomed Res Int; 2021; 2021():9025481. PubMed ID: 33564687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA-301b-3p accelerates migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis.
    Liu F; Zhang G; Lv S; Wen X; Liu P
    J Cell Biochem; 2019 Aug; 120(8):12618-12627. PubMed ID: 30834603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic microRNA-301b regulates tumor repressor dystrobrevin alpha to facilitate cell growth, invasion and migration in esophageal cancer.
    Fu G; Pei Z; Song N
    Esophagus; 2021 Apr; 18(2):315-325. PubMed ID: 32737801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Non-Coding RNA Metastasis Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Hypertension by Modulating the Hsa-miR-124-3p/Nuclear Receptor Subfamily 3, Group C, Member 2 (NR3C2) and Hsa-miR-135a-5p/NR3C2 Axis.
    Luo L; Wang Y; Hu P; Wu J
    Med Sci Monit; 2020 Mar; 26():e920478. PubMed ID: 32222724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profile and functional analysis of miR-301b in patients with breast cancer: A bioinformatics, biochemical, and histopathological study.
    Taha M; Yousef E; Badr AN; Salama RA; Maurice N
    Pathol Res Pract; 2024 Oct; 262():155536. PubMed ID: 39173462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD.
    Song H; Li D; Wu T; Xie D; Hua K; Hu J; Deng X; Ji C; Deng Y; Fang L
    BMB Rep; 2018 Nov; 51(11):602-607. PubMed ID: 30269739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-142-5p Acts as a Significant Regulator Through Promoting Proliferation, Invasion, and Migration in Breast Cancer Modulated by Targeting SORBS1.
    Yu W; Li D; Zhang Y; Li C; Zhang C; Wang L
    Technol Cancer Res Treat; 2019; 18():1533033819892264. PubMed ID: 31789129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia induced microRNA-301b-3p overexpression promotes proliferation, migration and invasion of prostate cancer cells by targeting LRP1B.
    Zheng H; Bai L
    Exp Mol Pathol; 2019 Dec; 111():104301. PubMed ID: 31442444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2.
    Zhang Z; Che X; Yang N; Bai Z; Wu Y; Zhao L; Pei H
    Biomed Pharmacother; 2017 Dec; 96():1341-1348. PubMed ID: 29196101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
    Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
    J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p.
    Xiao B; Chen D; Zhou Q; Hang J; Zhang W; Kuang Z; Sun Z; Li L
    BMC Cancer; 2019 Sep; 19(1):891. PubMed ID: 31492116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-induced microRNA-301b regulates apoptosis by targeting Bim in lung cancer.
    Wu D; Chen B; Cui F; He X; Wang W; Wang M
    Cell Prolif; 2016 Aug; 49(4):476-83. PubMed ID: 27352910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA NEAT1 accelerates breast cancer progression through regulating miR-410-3p/ CCND1 axis.
    Liu X; Yao W; Xiong H; Li Q; Li Y
    Cancer Biomark; 2020; 29(2):277-290. PubMed ID: 32675392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoliquiritigenin suppresses human melanoma growth by targeting miR-301b/LRIG1 signaling.
    Xiang S; Chen H; Luo X; An B; Wu W; Cao S; Ruan S; Wang Z; Weng L; Zhu H; Liu Q
    J Exp Clin Cancer Res; 2018 Aug; 37(1):184. PubMed ID: 30081934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.